Novel marine alkaloids from the tunicate Eudistoma sp. are potent regulators of cellular growth and differentiation and affect cAMP‐mediated processes
- 1 December 1993
- journal article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 157 (3) , 481-492
- https://doi.org/10.1002/jcp.1041570307
Abstract
Six novel alkaloids that contain a fused tetracyclic pyrido[2,3,4‐kl]acridine ring system were purified recently from the Red Sea purple tunicate Eudistoma sp. Evaluation of the effects of these alkaloids on cultured neuroblastoma and fibroblast cells revealed that they possess potent growth regulatory properties, and affect cell shape and adhesion. In mouse neuroblastoma cells, the Eudistoma alkaloids inhibited cell proliferation and induced a process of differentiation during which the cels flattened onto the surface, increased considerably in size, and extended long neurites. In hamster fibroblasts the alkaloids slowed down cell multiplication, and caused an exceptional cell flattening or elongation. In a virustransformed derivative of the hamster fibroblasts the alkaloids restored many aspects of normal cell growth and morphology. In addition, several of the alkaloids mimicked the effects of cAMP analogs on two well‐characterized cAMP‐mediated processes involved in hepatic glucose metabolism–inhibition of pyruvate kinase (PK) activity and induction of mRNA for phosphoenolpyruvate carboxykinase (PEPCK). All these effects suggest that the Eudistoma alkaloids may act on the cAMP signaling system. However, a single application of these compounds was sufficient to completely block cell multiplication and to induce and sustain differentiation and “reverse transformation”. Furthermore, these effects were not readily reversible following removal of the drugs. In contrast, a single application of agents that mimic or elevate cAMP induced a transient response that waned with time in culture, and the effects induced by constant elevation of cAMP reverse rapidly following drug removal. We propose that the Eudistoma alkaloids cause growth inhibition, differentiation, and reverse transformation by modifying the activity state of proteins that are involved in the regulation of cell shape and adhesion and serve as a target for the cAMP and/or other second messenger systems.Keywords
This publication has 40 references indexed in Scilit:
- Total synthesis of kuanoniamines and dercitinsJournal of the American Chemical Society, 1992
- Intracellular cyclic AMP produces effects opposite to those of cyclic GMP and calcium on shape and motility of neuroblastoma cellsCell Motility, 1992
- Substrate‐bound factors stimulate engorgement of growth cone lamellipodia during neurite elongationCell Motility, 1991
- Some Marine Ecological Phenomena: Chemical Basis and Biomedical PotentialScience, 1990
- Latrunculins—novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin DCell Motility, 1989
- Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolismNature, 1989
- Shermilamine A: A pentacyclic alkaloid from a tunicateThe Journal of Organic Chemistry, 1988
- Site‐selective cyclic AMP analogs provide a new approach in the control of cancer cell growthFEBS Letters, 1987
- Cellular signal transduction and the reversal of malignancyJournal of Cellular Biochemistry, 1987
- Differential Expression of the Genes for the Mitochondrial and Cytosolic Forms of Phosphoenolpyruvate CarboxykinaseaAnnals of the New York Academy of Sciences, 1986